Title : Phase II study of NGR-hTNF in combination with doxorubicin in relapsed ovarian cancer patients.

Pub. Date : 2012 Jun 26

PMID : 22644293






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND: The NGR-hTNF (asparagine-glycine-arginine-human tumour necrosis factor) is able to promote antitumour immune responses and to improve the intratumoural doxorubicin uptake by selectively damaging tumour blood vessels. Doxorubicin tumor necrosis factor Homo sapiens